These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2018362)

  • 1. Synthesis, mutagenicity, binding to pBR 322 DNA and antitumour activity of platinum(II) complexes with ethambutol.
    Coluccia M; Fanizzi FP; Giannini G; Giordano D; Intini FP; Lacidogna G; Loseto F; Mariggio MA; Nassi A; Natile G
    Anticancer Res; 1991; 11(1):281-7. PubMed ID: 2018362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, chemical characterization and biological evaluation of new platinum (II)-sulfonamide complexes.
    Craciunescu DG; Scarcia V; Furlani A; Parrondo Iglesias E; Ravalico L; Doadrio A
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):183-7. PubMed ID: 2334458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
    Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
    Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands].
    Brunner H; Nerl G; von Angerer E; Knebel N
    Arch Pharm (Weinheim); 1991 Oct; 324(10):779-84. PubMed ID: 1805710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.
    Coluccia M; Boccarelli A; Mariggiò MA; Cardellicchio N; Caputo P; Intini FP; Natile G
    Chem Biol Interact; 1995 Dec; 98(3):251-66. PubMed ID: 8548863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinuclear complexes of platinum having anticancer properties. DNA-binding studies and biological activity of bis(4,4'-dipyrazolylmethane-N,N')- bis[dichloroplatinum(II)] and related complexes.
    Broomhead JA; Rendina LM; Webster LK
    J Inorg Biochem; 1993 Feb; 49(3):221-34. PubMed ID: 8433090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
    Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
    Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
    Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New platinum (II) and platinum (IV) complexes with 1,2-diaminocyclohexane. Synthesis and in vitro and in vivo antitumour evaluation.
    Craciunescu DG; Furlani Candiani A; Scarcia V; Doadrio A; Ghirvu C
    J Pharm Belg; 1985; 40(2):79-84. PubMed ID: 4009393
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, spectroscopic, mutagenic, and cytotoxicity studies of some mixed-ligand platinum(II) complexes of 2,2'-bipyridine and amino acids.
    Jain N; Mital R; Ray KS; Srivastava TS; Bhattacharya RK
    J Inorg Biochem; 1987 Sep; 31(1):57-64. PubMed ID: 3320273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA in human cells.
    Whittaker J; McFadyen WD; Baguley BC; Murray V
    Anticancer Drug Des; 2001; 16(2-3):81-9. PubMed ID: 11962516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity.
    Coluccia M; Giordano D; Loseto F; Intini FP; Maresca L; Natile G
    Anticancer Res; 1989; 9(3):795-8. PubMed ID: 2548438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.